FI970716A0 - Menetelmiä primaarisen kohdun limakalvon liikakasvun estämiseksi - Google Patents

Menetelmiä primaarisen kohdun limakalvon liikakasvun estämiseksi

Info

Publication number
FI970716A0
FI970716A0 FI970716A FI970716A FI970716A0 FI 970716 A0 FI970716 A0 FI 970716A0 FI 970716 A FI970716 A FI 970716A FI 970716 A FI970716 A FI 970716A FI 970716 A0 FI970716 A0 FI 970716A0
Authority
FI
Finland
Prior art keywords
methods
preventing primary
mucosal hyperplasia
primary uterine
uterine mucosal
Prior art date
Application number
FI970716A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970716A (fi
Inventor
Robin Sharon Lee Fuchs-Young
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI970716A publication Critical patent/FI970716A/fi
Publication of FI970716A0 publication Critical patent/FI970716A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
FI970716A 1994-08-22 1997-02-20 Menetelmiä primaarisen kohdun limakalvon liikakasvun estämiseksi FI970716A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29412194A 1994-08-22 1994-08-22
PCT/US1995/010619 WO1996005832A1 (en) 1994-08-22 1995-08-21 Methods of inhibiting primary endometrial hyperplasia

Publications (2)

Publication Number Publication Date
FI970716A FI970716A (fi) 1997-02-20
FI970716A0 true FI970716A0 (fi) 1997-02-20

Family

ID=23131973

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970716A FI970716A0 (fi) 1994-08-22 1997-02-20 Menetelmiä primaarisen kohdun limakalvon liikakasvun estämiseksi

Country Status (20)

Country Link
EP (1) EP0771201B1 (xx)
JP (1) JPH10504579A (xx)
KR (1) KR970705388A (xx)
AT (1) ATE200623T1 (xx)
AU (1) AU706953B2 (xx)
CA (1) CA2198120A1 (xx)
CZ (1) CZ52297A3 (xx)
DE (1) DE69520741T2 (xx)
DK (1) DK0771201T3 (xx)
ES (1) ES2155895T3 (xx)
FI (1) FI970716A0 (xx)
GR (1) GR3036225T3 (xx)
HU (1) HUT76854A (xx)
IL (1) IL115018A0 (xx)
MX (1) MX9701359A (xx)
MY (1) MY131931A (xx)
NO (1) NO970787D0 (xx)
PT (1) PT771201E (xx)
WO (1) WO1996005832A1 (xx)
ZA (1) ZA956988B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2161964C2 (ru) * 1994-08-22 2001-01-20 Эли Лилли Энд Компани Способ ингибирования (угнетения) эндометриального рака
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
JPH07149638A (ja) * 1993-10-15 1995-06-13 Eli Lilly & Co 耐性新生物の治療法

Also Published As

Publication number Publication date
CA2198120A1 (en) 1996-02-29
JPH10504579A (ja) 1998-05-06
ZA956988B (en) 1997-02-21
AU706953B2 (en) 1999-07-01
HUT76854A (en) 1997-12-29
EP0771201A1 (en) 1997-05-07
DK0771201T3 (da) 2001-05-07
EP0771201A4 (en) 1997-09-10
FI970716A (fi) 1997-02-20
DE69520741T2 (de) 2001-10-11
ES2155895T3 (es) 2001-06-01
PT771201E (pt) 2001-07-31
NO970787L (no) 1997-02-20
WO1996005832A1 (en) 1996-02-29
KR970705388A (ko) 1997-10-09
GR3036225T3 (en) 2001-10-31
MY131931A (en) 2007-09-28
AU3409895A (en) 1996-03-14
EP0771201B1 (en) 2001-04-18
NO970787D0 (no) 1997-02-20
ATE200623T1 (de) 2001-05-15
IL115018A0 (en) 1995-12-08
DE69520741D1 (de) 2001-05-23
CZ52297A3 (en) 1997-08-13
MX9701359A (es) 1997-05-31

Similar Documents

Publication Publication Date Title
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
DE69430465D1 (de) Hemmung uteriner Fibrose
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
DE69412049D1 (de) Hemmung von dysfunctionalen Uterusblutungen
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
FI970716A0 (fi) Menetelmiä primaarisen kohdun limakalvon liikakasvun estämiseksi
MX9701333A (es) Metodos para inhibir el daño neuronal.
MX9701332A (es) Metodos para curar y reparar fracturas oseas.
MX9701328A (es) Metodos de reduccion de la cicatrizacion en la curacion de heridas.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9806036A (es) Compuestos para inhibir tumores en el colon.